Tandem Diabetes Care
TNDM
TNDM
337 hedge funds and large institutions have $7.32B invested in Tandem Diabetes Care in 2021 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 106 increasing their positions, 106 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more ownership
Funds ownership: 94.25% → 97.25% (+3%)
0% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 106
4% less call options, than puts
Call options by funds: $76.9M | Put options by funds: $80.4M
Holders
337
Holding in Top 10
9
Calls
$76.9M
Puts
$80.4M
Top Buyers
| 1 | +$273M | |
| 2 | +$53.3M | |
| 3 | +$50.4M | |
| 4 |
Goldman Sachs
New York
|
+$43.9M |
| 5 |
Bank of New York Mellon
New York
|
+$40.3M |
Top Sellers
| 1 | -$77M | |
| 2 | -$58.7M | |
| 3 | -$42.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$38.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20.8M |